Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |